27/02/2006 (Agence Europe) - As part of preparation for a vaccination campaign against a human flu pandemic, the European Medicines Agency has announced that it has received the second “core dossier” for future vaccine authorisation. This will involve the prototype of the vaccine elaborated by the US laboratory Chiron.